Search results for "cancer diagnosis"
Selected Filters:
FDA approves Roche's comprehensive pan-tumor liquid biopsy test for patients with solid tumors
FoundationOne Liquid CDx analyzes more than 300 cancer-related genes and multiple genomic signatures to inform treatment decisions for all solid tumor cancers
DM2000 & DM2000 LED Ergonomic system microscopes
Leica Microsystems EuropeWith their sophisticated modular design and high-performance fluorescence, the Leica DM2000 microscopes are ideal for complex tasks in pathology, cytology, and many other applications. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
Discover How Researchers at Rush Medical Center are Developing Novel Diagnostic Tests for Non-Small Cell Lung Cancer
Guest Editor, Yasha Talaga of MilliporeSigma, spoke to lead scientist, Dr Jeffrey Borgia to find out more
Clinical Highlights: Three-Person Babies, AI for Cancer Diagnostics & Automation Advances
Catch up on all the biggest stories and top downloadable content in the clinical community in our monthly round-up
A Spotlight on 8 Technologies Advancing Cancer Diagnostics and Therapeutic Monitoring
From 3D tissue profiling to intelligent surgical tools, discover some of the latest innovations set to revolutionize diagnostics in cancer
How PointMan™ Testing Kits Could Advance Non-Invasive Cancer Diagnostics
Dr Ricardo Del Sol discusses his collaboration with EKF Diagnostics
QIAamp DSP DNA Blood Mini Kit
QIAGENFor purification of genomic DNA from human whole blood for in vitro diagnostic use
FREND System: Microfluidic immunofluorescence analyzer
NanoEntekQuantitative immunoassay analyzing instrument that utilizes disposable cartridges to provide in vitro diagnostics results.
FREND System & Cartridges
NanoEntekQuantitative immunoassay analyzing instrument that utilizes disposable cartridge to provide in vitro diagnostics results.
Changes in breast cancer care in New York during the COVID-19 pandemic
Agilent highlights genomics and cell analysis solutions for cancer research at AACR 2022
Agilent Technologies showcased its cancer research innovations in cell analysis and genomics at the American Association for Cancer Research Annual Meeting
An AI model may predict elevated pancreatic cancer risk using electronic health records
Researchers have developed risk prediction algorithms for many forms of cancer as a result of recent breakthroughs in AI
3D Cell Culture: Tumor-specific cancer treatments, organoid quality, drug screening and more
Keep up to date with the latest research and discover the tools and techniques advancing 3D cell culture and its applications